Sai Parenterals Limited (SAIPARENT) fundamentals
Sai Parenterals Limited is a listed company in Pharmaceuticals & Biotechnology, part of the Healthcare sector, listed on the NSE as SAIPARENT (ISIN INE0H9F01037). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
Valuation and market data
| Last close | ₹526.50 |
|---|---|
| Market capitalisation | ₹1,722 crore |
| Enterprise value | ₹1,661 crore |
| P/E (TTM) | 120.76 |
| Price to book | 3.48 |
| Price to sales (TTM) | 2.47 |
| Book value per share | ₹151.39 |
| Dividend yield | 0.00% |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Listed since | Thu Apr 02 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹390 crore | ₹12 crore | ₹14 crore | 4.36 |
| Mar 2025 | ₹164 crore | ₹20 crore | ₹14 crore | 5.43 |
| Mar 2024 | ₹155 crore | ₹13 crore | ₹8 crore | 10.54 |
| Mar 2023 | ₹97 crore | ₹7 crore | ₹4 crore | 6.16 |
Figures are as reported (consolidated), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 51.2% |
|---|---|
| Foreign institutions (FII) | 4.0% |
| Mutual funds | 1.0% |
| Other domestic institutions | 7.5% |
| Retail and others | 36.3% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.